← OLAPLEX HOLDINGS, INC.
| Annual Trend | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|
| Amortization of patent formulations | $6.1m | $8.0m | $7.5m | $8.3m | $9.3m | $10.0m | |
| Amortization of other intangibles | $39.8m | $40.8m | $41.3m | $41.5m | $43.7m | $43.6m | |
| Depreciation of property and equipment | $0 | $162k | $363k | $479k | $486k | $345k | |
| Amortization of debt issuance costs | $1.8m | $2.8m | $1.5m | $1.8m | $1.8m | $3.9m | |
| Deferred taxes | ($4.4m) | $2.5m | $9.2m | $1.8m | $2.8m | $1.3m | |
| Share-based compensation expense | $1.5m | $4.0m | $7.3m | $9.1m | $11.1m | $13.3m | |
| Right-of-use assets obtained in exchange for new operating lease liabilities | — | $0 | $0 | $2.1m | $742k | $53k | |
| Net (loss) income | $39.3m | $220.8m | $244.1m | $61.6m | $19.5m | ($9.3m) | |
| Inventory write-off and disposal | $0 | $0 | $8.2m | $15.2m | $7.8m | $5.6m | |
| Tax Receivable Agreement liability adjustment | $0 | ($3.6m) | ($3.1m) | ($7.4m) | $3.9m | ($12.1m) | |
| Acquisition-related costs in investing activities | — | — | — | $0 | $0 | $9.3m | |
| Other | $0 | $0 | $412k | $1.1m | $3.5m | $1.7m | |
| Accounts receivable, net | ($7.1m) | ($26.4m) | ($5.4m) | $5.3m | $24.1m | ($14.5m) | |
| Inventory | ($14.2m) | ($63.7m) | ($52.6m) | $34.6m | $14.0m | $8.5m | |
| Prepaid expenses and other current assets | — | — | $850k | ($1.4m) | $1.5m | ($48.8m) | |
| Accounts payable | $14.9m | $2.4m | ($9.4m) | ($2.7m) | $3.1m | ($2.1m) | |
| Accrued expenses and other current liabilities | $8.8m | $19.6m | ($7.3m) | $8.7m | ($1.5m) | $50.3m | |
| Other assets and liabilities | $0 | $0 | ($6.2m) | ($467k) | ($2.3m) | ($2.4m) | |
| Purchase of property and equipment | ($27k) | ($875k) | ($650k) | ($375k) | ($1.1m) | ($331k) | |
| Acquisition-related costs | — | — | — | $0 | $0 | ($10.6m) | |
| Purchase of intangible assets | — | $0 | $0 | ($500k) | $0 | $0 | |
| Purchase and development of software | $0 | ($890k) | ($2.0m) | ($2.7m) | ($3.8m) | ($1.6m) | |
| Proceeds from exercise of stock options | $0 | $1.1m | $1.9m | $5.0m | $919k | $527k | |
| Principal payments of 2022 Term Loan Facility | ($10.7m) | ($20.1m) | ($780.4m) | ($8.4m) | ($6.8m) | ($301.7m) | |
| Payment related to shares withheld to cover tax withholding obligations for options and for SARs | $0 | $0 | ($774k) | ($10.4m) | $0 | $0 | |
| Payments made pursuant to Tax Receivable Agreement | — | — | $0 | ($16.5m) | ($12.8m) | ($12.1m) | |
| Noncash exercise of stock options | — | $0 | $0 | $13.7m | $0 | $0 | |
| Purchases of software not yet paid | — | — | $0 | $0 | $751k | $19k | |
| Net cash provided by operating activities | $129.0m | $200.0m | $255.3m | $177.5m | $143.1m | $58.7m | |
| Net cash used in investing activities | ($1.4b) | ($6.3m) | ($2.7m) | ($3.6m) | ($4.9m) | ($12.6m) | |
| Net cash used in financing activities | $1.3b | ($18.3m) | ($116.2m) | ($30.3m) | ($18.6m) | ($313.3m) | |
| Net (decrease) increase in cash and cash equivalents | $11.0m | $175.4m | $136.4m | $143.6m | $119.6m | ($267.2m) | |
| Cash and cash equivalents - beginning of year | $11.0m | $186.4m | $322.8m | $466.4m | $586.0m | $318.7m | |
| Cash paid during the year for interest | $34.6m | $58.3m | $41.2m | $59.6m | $59.9m | $34.3m | |
| Cash (refunded) paid for income taxes, net | $9.9m | $33.8m | $59.9m | $7.7m | $12.4m | ($91k) |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.